Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm
Authors
Keywords
LI-RADS, Hepatocellular carcinoma, Locoregional therapy, Response, RECIST
Journal
Abdominal Radiology
Volume 43, Issue 1, Pages 218-230
Publisher
Springer Nature
Online
2017-08-05
DOI
10.1007/s00261-017-1281-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and Reporting Criteria
- (2016) Ron C. Gaba et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Hepatic imaging following intra-arterial embolotherapy
- (2016) Joseph Ralph Kallini et al. Abdominal Radiology
- Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy
- (2016) Eric C. Ehman et al. Abdominal Radiology
- Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
- (2015) James J. Harding et al. CANCER
- Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST
- (2015) Ming Liu et al. EUROPEAN RADIOLOGY
- Interreader and inter-test agreement in assessing treatment response following transarterial embolization for hepatocellular carcinoma
- (2015) Olivio F. Donati et al. EUROPEAN RADIOLOGY
- Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging
- (2015) Elmar M. Merkle et al. EUROPEAN RADIOLOGY
- Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma
- (2015) Adeel R. Seyal et al. HEPATOLOGY
- MRI Findings and Prediction of Time to Progression of Patients with Hepatocellular Carcinoma Treated with Drug-eluting Bead Transcatheter Arterial Chemoembolization
- (2015) Seungsoo Lee et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
- (2015) Tomoki Kimura et al. PLoS One
- Stereotactic Body Radiotherapy-Induced Arterial Hypervascularity of Non-Tumorous Hepatic Parenchyma in Patients with Hepatocellular Carcinoma: Potential Pitfalls in Tumor Response Evaluation on Multiphase Computed Tomography
- (2014) Mee Jin Park et al. PLoS One
- Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update
- (2014) Muneeb Ahmed et al. RADIOLOGY
- Imaging Assessment of Hepatocellular Carcinoma Response to Locoregional and Systemic Therapy
- (2013) Vahid Yaghmai et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma
- (2013) Kenichi Takizawa et al. EUROPEAN JOURNAL OF RADIOLOGY
- Treatment of Hepatocellular Carcinoma Combining Sorafenib and Transarterial Locoregional Therapy: State of the Science
- (2013) Joshua L. Weintraub et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience and Review of Safety and Outcomes
- (2013) W. Cheung et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Enhancement Patterns of Hepatocellular Carcinoma After Transarterial Chemoembolization Using Drug-Eluting Beads on Arterial Phase CT Images: A Pilot Retrospective Study
- (2012) Woo-Suk Chung et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Is Gadoxetate Disodium–Enhanced MRI Useful for Detecting Local Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Therapy?
- (2012) Haruo Watanabe et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Pattern of Retained Contrast on Immediate Postprocedure Computed tomography (CT) After Particle Embolization of Liver Tumors Predicts Subsequent Treatment Response
- (2012) Xiaodong Wang et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Dynamic computed tomography appearance of tumor response after stereotactic body radiation therapy for hepatocellular carcinoma: How should we evaluate treatment effects?
- (2012) Tomoki Kimura et al. HEPATOLOGY RESEARCH
- Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602
- (2012) Yozo Sato et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Combination of Local Transcatheter Arterial Chemoembolization and Systemic Anti-angiogenic Therapy for Unresectable Hepatocellular Carcinoma
- (2012) Eleni Liapi et al. Liver Cancer
- MDCT Necrosis Quantification in the Assessment of Hepatocellular Carcinoma Response to Yttrium 90 Radioembolization Therapy
- (2011) Mauricio Stanzione Galizia et al. ACADEMIC RADIOLOGY
- Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma
- (2011) Weijing Sun et al. CANCER
- MRI contrast enhancement of malignant liver tumours following successful cryoablation
- (2011) Paul B. Shyn et al. EUROPEAN RADIOLOGY
- Maximum number of target lesions required to measure responses to transarterial chemoembolization using the enhancement criteria in patients with intrahepatic hepatocellular carcinoma
- (2011) Ju Hyun Shim et al. JOURNAL OF HEPATOLOGY
- Pseudolesion of the liver observed on gadoxetate disodium-enhanced magnetic resonance imaging obtained shortly after transarterial chemoembolization for hepatocellular carcinoma
- (2010) Yoshinobu Shinagawa et al. JAPANESE JOURNAL OF RADIOLOGY
- Stereotactic body radiation therapy: The report of AAPM Task Group 101
- (2010) Stanley H. Benedict et al. MEDICAL PHYSICS
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Assessment of Tumor Necrosis of Hepatocellular Carcinoma After Chemoembolization: Diffusion-Weighted and Contrast-Enhanced MRI With Histopathologic Correlation of the Explanted Liver
- (2009) Lorenzo Mannelli et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Radiologic findings following Y90 radioembolization for primary liver malignancies
- (2008) Saad M. Ibrahim et al. ABDOMINAL IMAGING
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Change in contrast enhancement of HCC on 1-month follow-up CT after local radiotherapy: An early predictor of final treatment response
- (2008) Eun Young Kim et al. EUROPEAN JOURNAL OF RADIOLOGY
- Molecular targeted therapies in hepatocellular carcinoma
- (2008) Josep M. Llovet et al. HEPATOLOGY
- Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2008) Abby B. Siegel et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiologic Monitoring of Hepatocellular Carcinoma Tumor Viability after Transhepatic Arterial Chemoembolization: Estimating the Accuracy of Contrast-enhanced Cross-sectional Imaging with Histopathologic Correlation
- (2008) Stephen J. Hunt et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started